ALK Rearrangement–Positive Pancreatic Cancer with Brain Metastasis Has Remarkable Response to ALK Inhibitors: A Case Report

Patients with metastatic pancreatic cancer typically have poor prognosis due to the limited effectiveness of existing treatment options. ALK rearrangement–positive is rare in pancreatic cancer, but may occur in those with KRAS-wild type. We present a 34-year-old young man with ALK rearrangement–posi...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Kai Ou, Xiu Liu, Weihua Li, Yi Yang, Jianming Ying, Lin Yang
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2021-09-01
Serie:	Frontiers in Oncology
Soggetti:	pancreatic cancer brain metastases ALK Kinase EML4-ALK fusion protein crizotinib alectinib
Accesso online:	https://www.frontiersin.org/articles/10.3389/fonc.2021.724815/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!